Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Debt Ratio of 0.07 in Q2 2024, up 81588.61% quarter-over-quarter from 0.0 in Q1 2024, and down 72.78% on a YoY basis from 0.26 in Q3 2023.
Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.07 for Q2 2024.
- In Q2 2024, Debt Ratio fell 72.78% year-over-year to 0.07; the TTM figure through Jun 2024 stood at 0.07 (down 72.78% YoY), while the FY2023 annual figure was 0.56, up 99.17% from the prior year.
- Debt Ratio was 0.07 for Q2 2024 at Corbus Pharmaceuticals Holdings, up from 0.0 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.56 in Q4 2023 to a low of 0.0 in Q1 2024.
- Historically, Debt Ratio has averaged 0.2 across 5 years, with a median of 0.18 in 2020.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 99.17% in 2023, then plunged 99.98% in 2024.
- A 5-year view of Debt Ratio shows it stood at 0.18 in 2020, then slipped by 5.53% to 0.17 in 2021, then soared by 62.9% to 0.28 in 2022, then jumped by 99.17% to 0.56 in 2023, then tumbled by 87.47% to 0.07 in 2024.
- The last three Debt Ratio figures came in at 0.07 (Q2 2024), 0.0 (Q1 2024), and 0.56 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.14 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.16 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.18 |
| Sep 30, 2020 | 0.19 |
| Dec 31, 2013 | 1.15 |